Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Timing of oxycodone injection for prevention of postoperative catheter-related bladder discomfort after ureteroscopic lithotripsy
ChiCTR2600119440Phase 4Not yet recruiting
- Sponsor
- The Second Affiliated Hospital of Zhengzhou University
- Start
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of oxycodone in cystitis (2 arms), sponsored by The Second Affiliated Hospital of Zhengzhou University. Primary endpoint: Incidence of catheter-related bladder discomfort (CRBD) within 4 hours after surgery. Planned start Feb 2026; status: not yet recruiting.
02
Drugs
oxycodone
03
Conditions
cystitis
Beyond the preview
Go deeper on ChiCTR2600119440.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600119440.